Important Safety Information
Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution
For Dogs Only
CAUTION:
- Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.
CONTRAINDICATIONS:
- Do not administer this product orally. (See WARNINGS.) Do not use this product (containing 2.5% moxidectin) on cats.
WARNINGS:
| For the first 30 minutes after application: Ensure that dogs cannot lick the product from application sites on themselves or other treated dogs, and separate treated dogs from one another and from other pets to reduce the risk of accidental ingestion. Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting, and generalized muscle tremors. In avermectin sensitive dogs, the signs may be more severe and may include coma and death. |
HUMAN WARNINGS:
- Children should not come in contact with the application site for two (2) hours after application.
PRECAUTIONS:
- Use with caution in sick, debilitated, or underweight animals.
- The safety of Advantage Multi® for Dogs has not been established in breeding, pregnant, or lactating dogs.
- The safe use of Advantage Multi® for Dogs has not been established in puppies and dogs less than 7 weeks of age or less than 3 lbs body weight.
- Prior to administration Advantage Multi® for Dogs, dogs should be tested for existing heartworm infections.
Advantage Multi is a registered trademark of Bayer.
X10289
| Copyright© Bayer HealthCare LLC, Animal Health Division | Conditions of Use| Privacy Statement| Imprint| About Us| Contact Us| Site Map |
|
Bayer and the Bayer Cross are registered trademarks of Bayer.
|